STLNStarling Oncology Inc. Common Stock

NAS · US · Healthcare · Medical Care Facilities · starlingoncology.com

6.465USD-2.93%Mkt Cap: 658.89M $P/E: —3d ago

Starling Oncology, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company of…

Industry Peers

Medical Care Facilities

Fresenius SE & Co. KGaA

$28.53BUSDP/E 16.8

THC

Tenet Healthcare Corporation

$22.61BUSDP/E 10.9

FME

Fresenius Medical Care AG & Co. KGaA

$11.72BUSDP/E 12.1

FMS

Fresenius Medical Care AG & Co. KGaA

$12.47BUSDP/E 12.2

EHC

Encompass Health Corporation

The Ensign Group, Inc.

$10.46BUSDP/E 28.1

UHS

Universal Health Services, Inc. Class B

LifeStance Health Group Inc. Common Stock

$4.76BUSDP/E 95.9

CON

Concentra Group Holdings Parent Inc. Common Stock

National HealthCare Corporation

$3.66BUSDP/E 26.2

OPCH

Option Care Health, Inc.

$3.55BUSDP/E 18.0

AVAH

Aveanna Healthcare Holdings Inc.

$2.87BUSDP/E 10.3

BKD

Brookdale Senior Living Inc.

Acadia Healthcare Company, Inc.

$2.59BUSD

Key Statistics

Company

Market Cap658.89M $

Enterprise Value730.23M $

Revenue (TTM)587.24M $

Gross Profit76.44M $

Net Income (TTM)-60.61M $

Revenue/Share5.814 USD

Last Price6.465 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees641

CountryUS

SectorHealthcare

IndustryMedical Care Facilities

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA-37.87

EV/Revenue1.24

P/S1.14

P/B-26.37

EPS (TTM)-0.28

EPS (Forward)—

52W Range

2.32088% of range7.050

52W High7.050 USD

52W Low2.320 USD

Profitability

Gross Margin15.20%

Oper. Margin-2.86%

EBITDA Margin-3.28%

Profit Margin-12.06%

ROE385.53%

ROA-36.81%

Growth

Revenue Growth34.60%

Earnings Growth—

Cash Flow & Leverage

Operating CF-24.59M $

CapEx (TTM)3.20M $

FCF Margin1.46%

FCF Yield1.30%

Net Debt63.70M $

Net Debt/EBITDA-3.30

Balance Sheet

Debt/Equity-6.60

Current Ratio1.36

Quick Ratio1.14

Book Value/Sh-0.2480 USD

Cash/Share0.4030 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating1.2 (Strong Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)9.000 USD

Upside (mean)+39.2%

Target Range7.000 USD – 11.00 USD

$7.000+39.2% to mean$11.00

# Analysts5

Ownership

Shares Out.101.92M

Float88.59M

Insiders18.08%

Institutions46.74%

Short Interest

Short Ratio3.3d

Short % Float8.30%

Short % Out.7.27%

Shares Short7.27M

Short (prev mo.)6.69M

Technical

SMA 505.522 (+17.1%)

SMA 2003.967 (+63.0%)

Beta0.42

S&P 52W Chg18.16%

Avg Vol (30d)1.89M

Avg Vol (10d)1.92M

Technical Indicators

RSI (14)62.0

MACD0.3323

MACD Signal0.2234

MACD Hist.+0.1088

BB Upper7.017 USD

BB Middle5.622 USD

BB Lower4.227 USD

BB Width49.62%

ATR (14)0.4442 USD

Vol Ratio (20d)0.91x